News and Events

Larry Gerrans

Larry Gerrans CEO Sanovas Discusses Pulmonary Diseases and Therapy Processes Under Development at Advamed 2011 on October 12, 2011

The company has about 25 current patents and the company has been in development for quite a while and has anticipated FDA approvals coming in the 2nd quarter of 2012.  The pulmonary disease and therapies are their focus both in the US and worldwide.

The company has developed a Smart Catheter with tools to allow access in areas to where it has been cumbersome or not minimally invasive procedures.  SanoVas has a software platform that includes direct visualization and #D orientation of the lungs.  Larry gives us a quick overview below.

“Sanovas technology and technique improve the standard of care; allowing the community interventionist to rescue the airway and provide safe, efficacious treatment as competently as the pulmonary oncologist”

FDA REGULATORY DISCLOSURE: Sanovas Inc. is an emerging technology company.
These products are investigational medical devices that have not been approved or cleared for use in the United States.